Abstract |
Cancer-specific splice variants gain significant interest as they generate neo- antigens that could be targeted by immune cells. CD20, a membrane antigen broadly expressed in mature B cells and in B cell lymphomas, is subject to an alternative splicing named D393-CD20 leading to loss of membrane expression of the spliced isoform. D393-CD20 expression is detectable in transformed B cells and upregulated in various lymphoma B cells. In this study, we show that D393-CD20 is translated in malignant B cells and that D393-CD20 specific CD4 T cells producing IFN-γ are present in B-cell lymphoma patients. Then, we have investigated whether the 20mer D393-CD20 peptide spanning the splicing site might be targeted by the immune system and we have shown that D393-CD20-specific CD4 Th1 clones could directly recognize malignant B cell lines and kill autologous lymphoma B cells indicating that D393-CD20-derived epitopes are naturally processed and presented on tumor cells. Finally, D393-CD20 peptide-based vaccination induced specific CD8 and CD4 T cell responses in HLA-humanized transgenic mice suggesting the presentation of D393-CD20 derived peptides on both HLA Class-I and -II. These findings support further investigations on the potential use of D393-CD20 directed specific immunotherapy in B cell malignancies.
|
Authors | Charline Vauchy, Clementine Gamonet, Christophe Ferrand, Etienne Daguindau, Jeanne Galaine, Laurent Beziaud, Adrien Chauchet, Carole J Henry Dunand, Marina Deschamps, Pierre Simon Rohrlich, Christophe Borg, Olivier Adotevi, Yann Godet |
Journal | International journal of cancer
(Int J Cancer)
Vol. 137
Issue 1
Pg. 116-26
(Jul 01 2015)
ISSN: 1097-0215 [Electronic] United States |
PMID | 25449106
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2014 UICC. |
Chemical References |
- Antigens, CD20
- Antigens, Neoplasm
- Epitopes, T-Lymphocyte
- Peptides
- Protein Isoforms
|
Topics |
- Alternative Splicing
- Animals
- Antigens, CD20
(genetics, immunology)
- Antigens, Neoplasm
(genetics, immunology)
- Cell Line, Tumor
- Epitopes, T-Lymphocyte
(immunology)
- Humans
- Immunization
- Lymphoma, B-Cell
(genetics, immunology, therapy)
- Mice
- Mice, Transgenic
- Peptides
(administration & dosage, immunology)
- Protein Isoforms
(genetics, metabolism)
- T-Lymphocytes, Helper-Inducer
(immunology)
|